Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Silo Pharma, Inc.Financial_Report.xls
EX-32.1 - SECTION 1350 CERTIFICATIONS OF RICHARD A. BRAND, THE PRINCIPAL EXECUTIVE OFFICER* - Silo Pharma, Inc.f10q0313ex32i_pointcapital.htm
EX-31.2 - RULE 13A-14(A)/15D14(A) CERTIFICATIONS OF VADIM MATS, THE PRINCIPAL FINANCIAL OFFICER* - Silo Pharma, Inc.f10q0313ex31ii_pointcapital.htm
10-Q - QUARTERLY REPORT - Silo Pharma, Inc.f10q0313_pointcapitalinc.htm
EX-31.1 - RULE 13A-14(A)/15D14(A) CERTIFICATIONS OF RICHARD A BRAND, THE PRINCIPAL EXECUTIVE OFFICER* - Silo Pharma, Inc.f10q0313ex31i_pointcapital.htm
EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
The undersigned, Vadim Mats, Chief Financial Officer of Point Capital, Inc. (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: May 15, 2013                                                                  
       
 
By:
/s/ Vadim Mats  
  Name:  Vadim Mats  
  Title:
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.